SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-03-002936
Filing Date
2003-03-18
Accepted
2003-03-18 16:06:24
Documents
11
Period of Report
2002-12-29

Document Format Files

Seq Description Document Type Size
1 JOHNSON & JOHNSON y83983e10vk.txt 10-K 66463
3 2000 STOCK OPTION PLAN (AS AMENDED) y83983exv10wb.txt EX-10.B 19186
4 DEFERRED FEE PLAN FOR DIRECTORS (AS AMENDED) y83983exv10wh.txt EX-10.H 15026
5 EXECUTIVE INCOME DEFERRAL PLAN (AS AMENDED) y83983exv10wi.txt EX-10.I 25119
6 LETTER AGREEMENT y83983exv10wo.txt EX-10.O 5752
7 CONSULTING AGREEMENT y83983exv10wp.txt EX-10.P 6987
8 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS y83983exv12.txt EX-12 3142
9 PAGES 28-58 OF 2002 ANNUAL REPORT TO SHAREHOLDERS y83983exv13.txt EX-13 183664
10 SUBSIDIARIES y83983exv21.txt EX-21 18974
11 CONSENT OF INDEPENDENT ACCOUNTANTS y83983exv23.txt EX-23 1009
12 CAUTIONARY STATEMENT y83983exv99wb.txt EX-99.B 6182
  Complete submission text file 0000950123-03-002936.txt   354248
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 001-03215 | Film No.: 03607809
SIC: 2834 Pharmaceutical Preparations